Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
McKinsey
Cipla
Teva
QuintilesIMS
Johnson and Johnson
Medtronic
Federal Trade Commission
Citi
Deloitte

Generated: January 19, 2018

DrugPatentWatch Database Preview

TEMOVATE Drug Profile

« Back to Dashboard

Which patents cover Temovate, and what generic alternatives are available?

Temovate is a drug marketed by Fougera Pharms and is included in five NDAs.

The generic ingredient in TEMOVATE is clobetasol propionate. There are thirteen drug master file entries for this compound. Thirty-seven suppliers are listed for this compound. Additional details are available on the clobetasol propionate profile page.
Drug patent expirations by year for TEMOVATE
Pharmacology for TEMOVATE
Medical Subject Heading (MeSH) Categories for TEMOVATE

US Patents and Regulatory Information for TEMOVATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fougera Pharms TEMOVATE clobetasol propionate CREAM;TOPICAL 019322-001 Dec 27, 1985 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Fougera Pharms TEMOVATE clobetasol propionate SOLUTION;TOPICAL 019966-001 Feb 22, 1990 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Fougera Pharms TEMOVATE clobetasol propionate GEL;TOPICAL 020337-001 Apr 29, 1994 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Fougera Pharms TEMOVATE clobetasol propionate OINTMENT;TOPICAL 019323-001 Dec 27, 1985 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Fougera Pharms TEMOVATE E clobetasol propionate CREAM;TOPICAL 020340-001 Jun 17, 1994 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for TEMOVATE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Fougera Pharms TEMOVATE clobetasol propionate CREAM;TOPICAL 019322-001 Dec 27, 1985 ➤ Subscribe ➤ Subscribe
Fougera Pharms TEMOVATE clobetasol propionate OINTMENT;TOPICAL 019323-001 Dec 27, 1985 ➤ Subscribe ➤ Subscribe
Fougera Pharms TEMOVATE clobetasol propionate SOLUTION;TOPICAL 019966-001 Feb 22, 1990 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Chubb
AstraZeneca
Dow
Moodys
Fish and Richardson
Mallinckrodt
Cantor Fitzgerald
US Department of Justice
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot